首页 › 股票 › NEUP

NEUP — NEUPHORIA THERAPEUTICS INC

申报持仓市值$9.72M
持有基金数(最新)37
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)13
机构持仓市值$2.75M · 773.35K 股
新建/增持/减仓/清仓2 / 3 / 2 / 12 · 更新于 2026-11-16
前五大/前十大集中度90.6% / 100.0%
机构整体持仓变动 增持 +5.0% (+36.68K 股)
机构持仓市值变动 下降 -14.5%

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 13 家机构在其最新 13F 申报中持有 NEUP(NEUPHORIA THERAPEUTICS INC),合计申报市值 $2.75M,对应 773.35K 股。按股数计算较上季度增持 5.0%(+36.68K 股),申报市值环比下降 14.5%。持仓集中度较高:前五大持有人占申报市值的 90.6%,前十大的集中度为 100.0%。

与上一季度相比,2 家新建仓位、3 家加仓、2 家减仓、12 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。

NEUPHORIA THERAPEUTICS INC(NEUP)的主要机构持有人包括 Lynx1 Capital Management LP、AdvisorShares Investments LLC、Balyasny Asset Management,按 13F 申报市值在本页 37 家持有人中排名居前。

NEUP 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 13 773.35K $2.75M +5.0%
Q2 2026 23 2.04M $8.93M +9.8%
Q1 2026 18 1.66M $6.75M +2.9%
Q4 2025 21 1.47M $5.69M +80.6%
Q3 2025 15 183.84K $2.17M -11.8%
Q2 2025 8 148.21K $1.05M -1.7%
Q1 2025 6 135.91K $778.68K -1.2%
Q4 2024 7 79.72K $273.44K —

表内 8 个季度中,机构持股合计增加 870%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+80.6%)。

前 25 大机构持仓人(Q3 2026) — 13 家基金

基金股数金额组合权重变化
AdvisorShares Investments LLC 312.89K $1.11M 0.14% 增持
VANGUARD CAPITAL MANAGEMENT LLC 173.49K $617.62K 0.00% 持有
Shay Capital LLC 130.02K $462.88K 0.06% 减持
Geode Capital Management 50.64K $180.26K 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 33.81K $120.35K 0.00% 持有
ADAR1 Capital Management, LLC 30.00K $106.80K 0.01% 持有
JANE STREET GROUP, LLC 18.17K $64.69K 0.00% 增持
BOOTHBAY FUND MANAGEMENT, LLC 14.00K $49.84K 0.00% 持有
Merck & Co., Inc. 历史持仓 10.03K $35.70K 0.00% 持有
UBS Group AG 224 $797 0.00% 减持
Morgan Stanley 58 $207 0.00% 持有
Fidelity Management & Research (FMR) 16 $57 0.00% 新进
BARCLAYS PLC 3 $11 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 23 家基金

基金股数金额组合权重变化
Lynx1 Capital Management LP 历史持仓 875.33K $3.83M 0.44% 持有
AdvisorShares Investments LLC 252.91K $1.11M 0.13% 增持
VANGUARD CAPITAL MANAGEMENT LLC 173.49K $758.14K 0.00% 新进
Shay Capital LLC 155.82K $680.94K 0.09% 增持
Balyasny Asset Management 142.23K $621.54K 0.00% 持有
Citadel Advisors 72.56K $317.08K 0.00% 增持
GEODE CAPITAL MANAGEMENT, LLC 49.52K $216.38K 0.00% 新进
Geode Capital Management 49.52K $216.38K 0.00% 减持
Ikarian Capital, LLC 47.44K $207.33K 0.03% 持有
VANGUARD FIDUCIARY TRUST CO 33.81K $147.73K 0.00% 增持
ADAR1 Capital Management, LLC 30.00K $131.10K 0.01% 持有
FNY Investment Advisers, LLC 26.50K $115.00K 0.05% 持有
Renaissance Technologies 25.50K $111.44K 0.00% 新进
XTX Topco Ltd 23.09K $100.90K 0.00% 新进
HRT FINANCIAL LP 22.86K $99.00K 0.00% 新进
JANE STREET GROUP, LLC 14.90K $65.13K 0.00% 新进
BOOTHBAY FUND MANAGEMENT, LLC 14.00K $61.18K 0.00% 持有
COMMONWEALTH EQUITY SERVICES, LLC 11.22K $49.04K 0.00% 持有
Northern Trust Corp 10.61K $46.37K 0.00% 新进
Merck & Co., Inc. 历史持仓 10.03K $43.82K 0.01% 持有
UBS Group AG 2.12K $9.25K 0.00% 减持
Morgan Stanley 58 $254 0.00% 持有
Caitong International Asset Management Co., Ltd 3 $13 0.00% 新进

Q1 2026 — 18 家基金

基金股数金额组合权重变化
Lynx1 Capital Management LP 历史持仓 875.33K $3.56M 0.56% 持有
AdvisorShares Investments LLC 155.37K $632.34K 0.12% 增持
Shay Capital LLC 151.01K $614.61K 0.10% 减持
Balyasny Asset Management 142.18K $578.68K 0.00% 新进
Squadron Capital Management LLC 76.73K $312.28K 0.13% 新进
Geode Capital Management 52.01K $211.67K 0.00% 增持
Ikarian Capital, LLC 47.44K $193.09K 0.02% 持有
VANGUARD FIDUCIARY TRUST CO 33.59K $136.71K 0.00% 新进
ADAR1 Capital Management, LLC 30.00K $122.10K 0.01% 持有
FNY Investment Advisers, LLC 26.50K $107.00K 0.06% 持有
Citadel Advisors 19.33K $78.68K 0.00% 新进
BOOTHBAY FUND MANAGEMENT, LLC 14.00K $56.98K 0.00% 持有
Virtu Financial LLC 12.03K $49.00K 0.00% 新进
COMMONWEALTH EQUITY SERVICES, LLC 11.22K $45.67K 0.00% 持有
Merck & Co., Inc. 历史持仓 10.03K $40.81K 0.01% 持有
UBS Group AG 2.32K $9.43K 0.00% 增持
RHUMBLINE ADVISERS 202 $822 0.00% 持有
Morgan Stanley 58 $236 0.00% 持有

Q4 2025 — 21 家基金

基金股数金额组合权重变化
Lynx1 Capital Management LP 历史持仓 875.23K $3.40M 0.69% 新进
Shay Capital LLC 169.06K $655.95K 0.10% 新进
AdvisorShares Investments LLC 134.19K $520.67K 0.09% 增持
DIADEMA PARTNERS LP 50.00K $194.00K 0.05% 增持
Ikarian Capital, LLC 47.44K $184.08K 0.02% 新进
ADAR1 Capital Management, LLC 30.00K $116.40K 0.01% 新进
FNY Investment Advisers, LLC 26.50K $102.00K 0.04% 新进
Vanguard Group 20.95K $81.29K 0.00% 持有
Geode Capital Management 17.30K $67.14K 0.00% 增持
JANE STREET GROUP, LLC 16.60K $64.40K 0.00% 增持
BRIDGEWAY CAPITAL MANAGEMENT, LLC 14.75K $57.23K 0.00% 新进
BOOTHBAY FUND MANAGEMENT, LLC 14.00K $54.32K 0.00% 新进
Persistent Asset Partners Ltd 13.40K $52.00K 0.03% 增持
XTX Topco Ltd 12.01K $46.59K 0.00% 新进
COMMONWEALTH EQUITY SERVICES, LLC 11.21K $43.48K 0.00% 新进
Merck & Co., Inc. 历史持仓 10.03K $38.91K 0.01% 持有
UBS Group AG 1.65K $6.41K 0.00% 减持
Tower Research Capital LLC (TRC) 1.40K $5.43K 0.00% 增持
RHUMBLINE ADVISERS 202 $783 0.00% 增持
Morgan Stanley 58 $225 0.00% 增持
Bank of America Corp 18 $70 0.00% 增持

Q3 2025 — 15 家基金

基金股数金额组合权重变化
AdvisorShares Investments LLC 58.56K $690.46K 0.11% 减持
DIADEMA PARTNERS LP 21.45K $252.92K 0.09% 新进
Vanguard Group 20.95K $247.00K 0.00% 新进
MILLENNIUM MANAGEMENT LLC 18.33K $216.10K 0.00% 新进
Millennium Management 18.33K $216.10K 0.00% 新进
JANE STREET GROUP, LLC 15.67K $184.74K 0.00% 新进
Geode Capital Management 12.98K $153.01K 0.00% 新进
Merck & Co., Inc. 历史持仓 10.03K $118.22K 0.05% 持有
Persistent Asset Partners Ltd 4.91K $57.87K 0.04% 新进
UBS Group AG 2.17K $25.56K 0.00% 新进
Tower Research Capital LLC (TRC) 410 $4.83K 0.00% 新进
RHUMBLINE ADVISERS 33 $389 0.00% 持有
Bank of America Corp 17 $201 0.00% 增持
Morgan Stanley 7 $83 0.00% 持有
Fidelity Management & Research (FMR) 2 $24 0.00% 新进

Q2 2025 — 8 家基金

基金股数金额组合权重变化
AdvisorShares Investments LLC 67.73K $480.90K 0.09% 减持
Lynx1 Capital Management LP 历史持仓 45.81K $325.22K 0.09% 持有
Citadel Advisors 14.61K $103.70K 0.00% 新进
Merck & Co., Inc. 历史持仓 10.03K $71.19K 0.03% 持有
Cyndeo Wealth Partners, LLC 10.00K $71.00K 0.00% 持有
RHUMBLINE ADVISERS 33 $234 0.00% 减持
Morgan Stanley 7 $50 0.00% 持有
Bank of America Corp 1 $7 0.00% 新进

查看全部 37 家持有基金 →

新建仓(Q3 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
AdvisorShares Investments LLC 312.89K 252.91K 155.37K 134.19K 58.56K 67.73K 69.66K —
VANGUARD CAPITAL MANAGEMENT LLC 173.49K 173.49K — — — — — —
Shay Capital LLC 130.02K 155.82K 151.01K 169.06K — — — —
Geode Capital Management 50.64K 49.52K 52.01K 17.30K 12.98K — — —
VANGUARD FIDUCIARY TRUST CO 33.81K 33.81K 33.59K — — — — —
ADAR1 Capital Management, LLC 30.00K 30.00K 30.00K 30.00K — — — —
JANE STREET GROUP, LLC 18.17K 14.90K — 16.60K 15.67K — — 13.31K
BOOTHBAY FUND MANAGEMENT, LLC 14.00K 14.00K 14.00K 14.00K — — — —
Merck & Co., Inc. 10.03K 10.03K 10.03K 10.03K 10.03K 10.03K 10.03K 10.03K
UBS Group AG 224 2.12K 2.32K 1.65K 2.17K — — 2.98K
Morgan Stanley 58 58 58 58 7 7 7 7
Fidelity Management & Research (FMR) 16 — — — 2 — — —
BARCLAYS PLC 3 — — — — — — —
Lynx1 Capital Management LP — 875.33K 875.33K 875.23K — 45.81K 45.81K 45.81K
Balyasny Asset Management — 142.23K 142.18K — — — — —
Citadel Advisors — 72.56K 19.33K — — 14.61K — —
Squadron Capital Management LLC — — 76.73K — — — — —
DIADEMA PARTNERS LP — — — 50.00K 21.45K — — —
Vanguard Group — — — 20.95K 20.95K — — —
GEODE CAPITAL MANAGEMENT, LLC — 49.52K — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold NEUP?

As of 2026-Q3, 13 institutional funds reported holding NEUP (NEUPHORIA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.75M.

How many shares of NEUP do institutions own?

13F filers reported 773.35K shares of NEUP, worth $2.75M in aggregate at the end of 2026-Q3.

Is institutional ownership of NEUP rising or falling?

Share counts moved +5.0% versus the prior quarter — accumulation.

Who are the top institutional holders of NEUP?

The largest 13F holders are Lynx1 Capital Management LP, AdvisorShares Investments LLC, Balyasny Asset Management, VANGUARD CAPITAL MANAGEMENT LLC, Shay Capital LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of NEUPHORIA THERAPEUTICS INC?

The major shareholders of NEUPHORIA THERAPEUTICS INC (NEUP) by reported 13F value are Lynx1 Capital Management LP, AdvisorShares Investments LLC, Balyasny Asset Management, VANGUARD CAPITAL MANAGEMENT LLC, Shay Capital LLC, among 37 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 NEUP」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/NEUP/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →